1. Home
  2. DMRA vs CRI Comparison

DMRA vs CRI Comparison

Compare DMRA & CRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$31.80

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Logo Carter's Inc.

CRI

Carter's Inc.

HOLD

Current Price

$37.56

Market Cap

1.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
DMRA
CRI
Founded
2011
1865
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2020
2002

Fundamental Metrics

Financial Performance
Metric
DMRA
CRI
Price
$31.80
$37.56
Analyst Decision
Buy
Hold
Analyst Count
2
6
Target Price
$43.00
$35.60
AVG Volume (30 Days)
372.2K
1.0M
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
2.74%
EPS Growth
121.48
N/A
EPS
N/A
3.26
Revenue
N/A
$2,898,426,000.00
Revenue This Year
N/A
$4.57
Revenue Next Year
N/A
$1.12
P/E Ratio
N/A
$11.60
Revenue Growth
N/A
1.91
52 Week Low
$16.50
$24.71
52 Week High
$34.89
$44.44

Technical Indicators

Market Signals
Indicator
DMRA
CRI
Relative Strength Index (RSI) 60.76 41.27
Support Level $22.71 $37.18
Resistance Level $31.77 $39.16
Average True Range (ATR) 1.63 1.51
MACD 0.02 -0.16
Stochastic Oscillator 87.75 39.18

Price Performance

Historical Comparison
DMRA
CRI

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

Share on Social Networks: